Pulmonx logo

Pulmonx

Minimally invasive medical devices for treating severe emphysema.

What they do

The company develops and manufactures endobronchial valves and assessment tools designed for lung volume reduction. Interventional pulmonologists purchase these devices to treat severe emphysema patients, helping them breathe easier and improve their overall quality of life.

The record

Vertical
Medical Devices
Sub-segment
Respiratory devices
Product type
Device
Stage
Public
Headquarters
Redwood City, USA
Region
North America
Founded
1995
Total funding
$120M raised

Notable investors: Ally Bridge Group, Boston Scientific, Apax Partners.

Also in Medical Devices

See the Medical Devices market map

Related on The Signal